The ISAQ Score Does Not Predict Adrenal Crisis in Patients with Primary Adrenal Insufficiency
Thieme. All rights reserved..
OBJECTIVE: This study aimed to investigate the ability of the immune system assessment questionnaire (ISAQ) to predict adrenal crisis (AC) and infectious events in patients with primary adrenal insufficiency (PAI).
DESIGN: This was a prospective single-centre study over three years.
METHODS: Patients answered the ISAQ at baseline and were seen every 4-6 months in the endocrine outpatient clinic. At each visit previous infectious periods which required an increase in daily glucocorticoid dosage and AC were reported and documented. Seventy-five patients with PAI (53 women; 43 patients with autoimmune PAI, 20 patients with salt-wasting congenital adrenal hyperplasia and 12 patients who underwent bilateral adrenalectomy) were analysed. Due to the COVID-19 pandemic and consecutive lockdown measures, the data were analysed separately for March 2018 to March 2020 (period 1), and March 2020 to March 2021 (period 2).
RESULTS: During period 1 the ISAQ score significantly correlated with the number of reported infectious events (r=0.351; p<0.01), but not during period 2 (r=0.059, p=0.613), in which the number of infectious events per patient-year significantly decreased (1.1±0.1 vs 0.4±0.1; p<0.001). The frequency of AC decreased from 8.8 to 2.4 per 100 patient-years between the two study periods. The ISAQ score was not different between patients with or without AC.
CONCLUSIONS: The ISAQ score does not identify patients prone to ACs. The COVID-19 pandemic and consecutive lockdown measures significantly diminished the frequency of infectious events and ACs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:130 |
---|---|
Enthalten in: |
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association - 130(2022), 8 vom: 29. Aug., Seite 554-560 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Quinkler, Marcus [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 15.08.2022 Date Revised 15.08.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/a-1734-2466 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337719012 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337719012 | ||
003 | DE-627 | ||
005 | 20231225235044.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/a-1734-2466 |2 doi | |
028 | 5 | 2 | |a pubmed24n1125.xml |
035 | |a (DE-627)NLM337719012 | ||
035 | |a (NLM)35240692 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Quinkler, Marcus |e verfasserin |4 aut | |
245 | 1 | 4 | |a The ISAQ Score Does Not Predict Adrenal Crisis in Patients with Primary Adrenal Insufficiency |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.08.2022 | ||
500 | |a Date Revised 15.08.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a OBJECTIVE: This study aimed to investigate the ability of the immune system assessment questionnaire (ISAQ) to predict adrenal crisis (AC) and infectious events in patients with primary adrenal insufficiency (PAI) | ||
520 | |a DESIGN: This was a prospective single-centre study over three years | ||
520 | |a METHODS: Patients answered the ISAQ at baseline and were seen every 4-6 months in the endocrine outpatient clinic. At each visit previous infectious periods which required an increase in daily glucocorticoid dosage and AC were reported and documented. Seventy-five patients with PAI (53 women; 43 patients with autoimmune PAI, 20 patients with salt-wasting congenital adrenal hyperplasia and 12 patients who underwent bilateral adrenalectomy) were analysed. Due to the COVID-19 pandemic and consecutive lockdown measures, the data were analysed separately for March 2018 to March 2020 (period 1), and March 2020 to March 2021 (period 2) | ||
520 | |a RESULTS: During period 1 the ISAQ score significantly correlated with the number of reported infectious events (r=0.351; p<0.01), but not during period 2 (r=0.059, p=0.613), in which the number of infectious events per patient-year significantly decreased (1.1±0.1 vs 0.4±0.1; p<0.001). The frequency of AC decreased from 8.8 to 2.4 per 100 patient-years between the two study periods. The ISAQ score was not different between patients with or without AC | ||
520 | |a CONCLUSIONS: The ISAQ score does not identify patients prone to ACs. The COVID-19 pandemic and consecutive lockdown measures significantly diminished the frequency of infectious events and ACs | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Kienitz, Tina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association |d 1996 |g 130(2022), 8 vom: 29. Aug., Seite 554-560 |w (DE-627)NLM075292904 |x 1439-3646 |7 nnns |
773 | 1 | 8 | |g volume:130 |g year:2022 |g number:8 |g day:29 |g month:08 |g pages:554-560 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1734-2466 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 130 |j 2022 |e 8 |b 29 |c 08 |h 554-560 |